Valeant Officials, Blasted By Lawmakers For ‘Immoral’ Pricing Practices, Admit To Making Mistakes
“Pigs get fed, hogs get slaughtered. It’s time to slaughter some hogs,” Sen. Claire McCaskill said in opening the committee hearing on high drug prices. Valeant's outgoing CEO J. Michael Pearson offered his regrets to a skeptical panel, while investor Bill Ackman promised a shift in pricing strategy going forward.
The Associated Press:
Lawmakers Blast Valeant For Price-Gouging Tactics
The New York Times:
Valeant Chief Says It Made Mistakes On Aggressive Drug Pricing
Reuters:
Ackman, Valeant Pledge Reforms After Spiking Drug Prices
USA Today:
Senate Told Valeant Drug Price Hikes Hurt Patients
The Wall Street Journal:
Valeant Pharmaceuticals To Make Sweeping Changes To Board